Lucira Health, Inc. (LHDX)
| Market Cap | 229.10M |
| Revenue (ttm) | 17.22M |
| Net Income (ttm) | n/a |
| Shares Out | 38.48M |
| EPS (ttm) | -3.52 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 124,221 |
| Open | 5.90 |
| Previous Close | 5.87 |
| Day's Range | 5.76 - 5.96 |
| 52-Week Range | 4.23 - 37.99 |
| Beta | n/a |
| Analysts | Hold |
| Price Target | 7.25 (+23.1%) |
| Est. Earnings Date | Nov 11, 2021 |
About LHDX
Lucira Health, Inc., a medical technology company, focuses on the development and commercialization of infectious disease test kits. It develops a testing platform that produces molecular testing services. The company offers LUCIRA COVID-19 All-In-One Test Kit, a COVID-19 test kit; and develops influenza A and B viruses test kits. It has a patent license agreement with Eiken Chemical Co., Ltd.; technical services agreement with Jabil, Inc.; and manufacturing services agreement with Jabil MSA. The company was formerly known as DiAssess Inc. and ...
Financial Performance
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for Lucira Health stock is "Hold." The 12-month stock price forecast is 7.25, which is an increase of 23.09% from the latest price.
News
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lucira Health, Inc. - LHDX
NEW YORK, Oct. 15, 2021 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Lucira Health, Inc. ("Lucira" or the "Company") (NASDAQ: LHDX). Such investors are advised to con...
LUCIRA™ HEALTH COVID-19 Test Approved for Sale in Singapore
Singapore Health Sciences Authority issues approval by its Pandemic Special Access Route (PSAR) for the LUCIRA CHECK IT COVID-19 Test Kit. Lucira has partnered with Labgistics Asia Pte Ltd for the impor...
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Lucira Health, Inc. - LHDX
New York, New York--(Newsfile Corp. - October 8, 2021) - Pomerantz LLP is investigating claims on behalf of investors of Lucira Health, Inc. ("Lucira" or the "Company") (NASDAQ: LHDX). Such investors ar...
LUCIRA™ HEALTH Provides Statement on Copan's Recall of its FLOQSwabs
EMERYVILLE, Calif., Oct. 08, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of t...
LUCIRA™ HEALTH Hires Tony Allen as Chief Operations Officer
Veteran operations expert joins Lucira's management team Veteran operations expert joins Lucira's management team
LUCIRA™ HEALTH Hires Ghazi Kashmolah as Chief Quality Officer and EVP Regulatory Affairs
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (“Lucira Health” or “Lucira”) (NASDAQ: LHDX), a medical technology company focused on the development and commercialization of transformative and...
3 Beaten-Down Biotech Stocks to Buy Right Now
These biotech stocks might be down, but they're not out.
Lucira Health Stock Soars After Q2 Sales Jump 175% Sequentially
Lucira Health Inc (NASDAQ: LHDX) reported sales of $12.4 million in Q2, the firm's second full quarter of commercial activity, beating the consensus estimate of $8 million. Sales increased 175% sequenti...
Lucira Health Announces Second Quarter 2021 Financial Results
EMERYVILLE, Calif., Aug. 12, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (Nasdaq: LHDX) ("Lucira Health," "Lucira" or the "Company"), a medical technology company focused on the development and commerc...
2 Under-the-Radar Stocks to Buy Now
The stocks have huge upside potential that investors are overlooking.
5 Stocks to Own for the Surge in Coronavirus Variants
Despite easing restrictions, COVID is going to be around a lot longer than many think.
Why Lucira Health Is Rocketing Higher Today
The company may be the beneficiary of another social media-inspired buying frenzy.
LUCIRA™ HEALTH Hires Chief Revenue Officer Kevin Collins
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
Is Lucira Health a Good Stock to Buy Right Now?
This start-up's over-the-counter COVID-19 tests could be a huge hit.
Lucira Health Announces First Quarter 2021 Financial Results
EMERYVILLE, Calif, May 13, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. ("Lucira Health," "Lucira" or the "Company") (NASDAQ: LHDX), a medical technology company focused on the development and commercia...
Why Second Sight Medical, Lucira Health, RA Medical Are Moving Today
Second Sight Medical Products, Inc. (NASDAQ: EYES), Lucira Health, Inc. (NASDAQ: LHDX) and Ra Medical Systems, Inc. (NYSE: RMED) were among the biggest health care gainers Wednesday. Second Sight Rallie...
Lucira Health to Participate in Upcoming BofA Securities 2021 Virtual Healthcare Conference
EMERYVILLE, Calif., May 06, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of tr...
Is Lucira Health a Buy?
This coronavirus testing stock has taken shareholders on a roller-coaster ride since its IPO.
Lucira Health to Announce First Quarter 2021 Financial Results
EMERYVILLE, Calif., April 29, 2021 (GLOBE NEWSWIRE) -- Lucira Health, Inc. (“Lucira Health” or “Lucira”) (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of ...
Lucira Health Celebrates Grand Opening of New Jabil Manufacturing Plant, Increasing Production of LUCIRA CHECK IT™ CO...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
Health Canada Authorizes First COVID-19 Test For Self-Testing At Home
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
For the First Time Ever, NBA Fans Can Test Themselves for COVID-19 Before Attending a Live Game. Testing Program Debu...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...
Why Lucira Health Stock Is Plunging Today
This analyst thinks the company's stock performance will trail that of the market.
Why Lucira Health Stock Skyrocketed Today
The company's COVID-19 Test Kit will soon be available for sale at a pharmacy near you.
FDA Authorizes First Single-Use, PCR Quality Over the Counter (OTC) LUCIRA CHECK IT™ COVID-19 At-Home Test. Available...
EMERYVILLE, Calif.--(BUSINESS WIRE)--Lucira Health, Inc. (Nasdaq: LHDX), a medical technology company focused on the development and commercialization of transformative and innovative infectious disease...